172 results on '"Auvity, Sylvain"'
Search Results
2. Brain PET imaging using 11C-flumazenil and 11C-buprenorphine does not support the hypothesis of a mutual interaction between buprenorphine and benzodiazepines at the neuroreceptor level
3. In mice and humans, brain microvascular contractility matures postnatally
4. Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences
5. A pharmacological imaging challenge based on 11C-buprenorphine PET-MRI to explore the response to opioids in humans
6. Mechanisms of respiratory depression induced by the combination of buprenorphine and diazepam in rats
7. Translational Preclinical PET Imaging and Metabolic Evaluation of a New Cannabinoid 2 Receptor (CB2R) Radioligand, (Z)‑N‑(3-(2-(2‑[18F]Fluoroethoxy)ethyl)-4,5-dimethylthiazol-2(3H)‑ylidene)-2,2,3...
8. Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers?
9. Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo
10. An original radio-biomimetic approach to synthesize radiometabolites for PET imaging
11. Automated two-step manufacturing of [11C]glyburide radiopharmaceutical for PET imaging in humans
12. Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated
13. European Association of Hospital Pharmacists (EAHP) Guidance on the Pharmacy Handling of In Vivo Gene Therapy Medicinal Products
14. Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB
15. Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice?
16. Physical blood-brain barrier disruption induced by focused ultrasound does not overcome the transporter-mediated efflux of erlotinib
17. Brain PET imaging using 11 C-flumazenil and 11 C-buprenorphine does not support the hypothesis of a mutual interaction between buprenorphine and benzodiazepines at the neuroreceptor level.
18. Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated.
19. Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences
20. A major role for CD4+ T cells in driving cytokine release syndrome during CAR T cell therapy
21. Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal
22. Parametric Imaging of P-Glycoprotein Function at the Blood–Brain Barrier Using kE,brain-maps Generated from [11C]Metoclopramide PET Data in Rats, Nonhuman Primates and Humans.
23. Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primates
24. Parametric imaging of P-glycoprotein function at the blood-brain barrier using kE,brain-maps generated from [11C]metoclopramide PET data in rats, nonhuman primates and humans
25. Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease
26. Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [11C]-N-desmethyl-loperamide PET study in nonhuman primates
27. Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood–Brain Barrier
28. European Association of Hospital Pharmacists (EAHP) guidance on the pharmacy handling of in vivo gene therapy medicinal products
29. Dissimilar Effect of P‑Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.
30. In mice and humans, brain microvascular contractility matures postnatally
31. TSPO PET Imaging as a Potent Non-Invasive Biomarker for Diffuse Intrinsic Pontine Glioma in a Patient-Derived Orthotopic Rat Model
32. Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats
33. Diphenhydramine as a selective probe to study H+-antiporter function at the blood–brain barrier: Application to [11C]diphenhydramine positron emission tomography imaging
34. In mice and humans, brain microvascular contractility matures postnatally Brain microvessel post-natal maturation
35. In Mice and Humans, Brain Vascular Barrier Homeostasis and Contractility Are Acquired Postnatally
36. Validation of a simple HPLC-UV method for rifampicin determination in plasma: Application to the study of rifampicin arteriovenous concentration gradient
37. Comparative vulnerability of PET radioligands to partial inhibition of P-glycoprotein at the blood-brain barrier: A criterion of choice?
38. Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [18F]DPA-714, a positron emission tomography imaging marker of glial activation
39. Voriconazole topical cream formulation: evidence for stability and antifungal activity
40. In mice and humans, the brain’s blood vessels mature postnatally to acquire barrier and contractile properties
41. Assessment of practices for suspended oral drugs by tablet crushing in pediatric units
42. Corrigendum to “Evaluation of TSPO PET imaging, a marker of glial activation, to study the neuroimmune footprints of morphine exposure and withdrawal” [Drug Alcohol Depend. 170 (2017) 43–50]
43. Imaging the neuroimmune response to alcohol exposure in adolescent baboons: a TSPO PET study using [$^{18}$F]DPA-714
44. Imaging the neuroimmune response to alcohol exposure in adolescent baboons: a TSPO PET study using 18 F-DPA-714
45. Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB
46. Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans
47. Impact of Acute Alcohol Exposure on P‐Glycoprotein Function at the Blood‐Brain Barrier Assessed Using 11 C‐Metoclopramide PET Imaging
48. Acute Morphine Exposure Increases the Brain Distribution of [ 18 F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates
49. Impact of P-glycoprotein Function on the Brain Kinetics of the Weak Substrate 11C-Metoclopramide Assessed with PET Imaging in Humans.
50. P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of 11C-Metoclopramide Across the Blood–Brain Barrier: A PET Study on Nonhuman Primates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.